141
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Community pharmacists’ knowledge of COPD, and practices and perceptions of medication counseling of COPD patients

, , , &
Pages 2065-2074 | Published online: 03 Jul 2018

References

  • Global Initiative for Chronic Obstructive Lung Disease (GOLD)From the global strategy for the diagnosis, management and prevention of COPD2016 Available from: http://goldcopd.org/Accessed September 10, 2017
  • BurneyPPatelJNewsonRMinelliCNaghaviMGlobal and regional trends in COPD mortality, 1990–2010Eur Respir J2015451239124725837037
  • KainuARouhosASovijärviALindqvistASarnaSLundbäckBCOPD in Helsinki, Finland: socioeconomic status based on occupation has an important impact on prevalenceScand J Public Health20134157058023599377
  • VasankariTMImpivaaraOHeliövaaraMNo increase in the prevalence of COPD in two decadesEur Respir J20103676677320693258
  • KanervistoMVasankariTLaitinenTHeliövaaraMJousilahtiPSaarelainenSLow socioeconomic status is associated with chronic obstructive airway diseasesRespir Med20111051140114621459567
  • KainuAPallasahoPPietinalhoANo change in prevalence of symptoms of COPD between 1996 and 2006 in Finnish adults – a report from the FinEsS Helsinki StudyEur Clin Respir J201633178027534614
  • National Institute for Health and Welfare, Chronic Diseases, general information2014 Available from: https://thl.fi/en/web/chronic-diseases/general-information-about-chronic-diseases-affecting-public-healthAcccessed September 10, 2017
  • Working Group appointed by the Finnish Medical Society Duodecim and the Finnish Respiratory SocietyCurrent care guideline of chronic obstructive pulmonary disease (COPD)2014 Available from: http://www.kaypahoito.fi/web/kh/suositukset/suositus?id=hoi06040Accessed September 10, 2017
  • KankaanrantaHHarjuTKilpeläinenMDiagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the Finnish guidelinesBasic Clin Pharmacol Toxicol201511629130725515181
  • National Institute for Health and Care ExcellenceQuality standard: chronic obstructive pulmonary disease in adults2016 Available from: https://www.nice.org.uk/guidance/qs10Accessed September 10, 2017
  • MiravittlesMVogelmeierCRocheNA review of national guidelines for management of COPD in EuropeEur Respir J20164762563726797035
  • van der MolenTvan BovenJMguireTGoyalPAltmanPOptimizing identification and management of COPD patients – reviewing the role of the community pharmacistBr J Clin Pharmacol20178319220127510273
  • OttenbrosSTeichertMde GrootRPharmacist-led intervention study to improve drug therapy in asthma and COPD patientsInt J Clin Pharmacol201436336344
  • van BovenJStuurman-BiezeAHiddinkEGPostmaMJEffects of targeting disease and medication management interventions towards patients with COPDCurr Med Res Opin20163222923926479017
  • WrightDTwiggMBartonGThornleyTKerrCAn evaluation of a multi-site community pharmacy-based chronic pulmonary disease serviceInt J Pharm Pract201523364325409898
  • Medicines Act 398/1987, Ministry of Social Affairs and Health2017 Available from: http://www.finlex.fi/fi/laki/ajantasa/1987/19870395Accessed September 10, 2017
  • BellJSVäänänenMOvaskainenHNärhiUAiraksinenMProviding patient care in community pharmacies: practise and research in FinlandAnn Pharmacother2007411039104617504836
  • MononenANiskanenANummiSApteekkien astmaohjelman seurantatutkimukset [Implementation of the National Asthma Programme in Finnish Community Pharmacies]Dosis201027100113 Finnish
  • PietinalhoAKinnulaVLSovijärviARChronic bronchitis and chronic obstructive pulmonary disease. The Finnish Action Programme, interim reportRespir Med20071011419142517353122
  • HaahtelaTvon HertzenLMäkeläMHannukselaMAllergy Programme Working GroupFinnish Allergy Programme 2008–2018 – time to act and change the courseAllergy20086363464518445181
  • KinnulaVVasankariTKontulaESovijärviASäynäjakangasOPietinalhoAThe 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortalityPrim Care Respir J20112017818321431275
  • KauppiPPeuraSSalimäkiJJärvenpääSLinnaMHaahtelaTReduced severity and improved control of self-reported asthma in Finland during 2001–2010Asia Pac Allergy201453239
  • AiraksinenMPohjanoksa-MäntyläMPuumalainenITheoretical basis and context of the patient counselling services by pharmacists, counselling, in the booklet concordance, communication, innovation education for pharmacists by International Pharmaceutical Federation (FIP) and IPFS2012 Available from: https://fip.org/files/fip/HaMIS/fip_ipsf_pce_2nd_2012.pdfAccessed September 10, 2017
  • PuumalainenIHalonenPEnlundHJohnsonKAiraksinenMValidation of the United States Pharmacopeia (USP) medication counseling behavior guidelinesPharm Educ200558796
  • PuumalainenIKansanahoHVarunkiMAhonenRAiraksinenMUsefulness of the USP Medication Counselling Behavior GuidelinePharm World Sci20052746546816341955
  • Finnish Advisory Board on Research IntegrityResponsible conduct of research and procedures for handling allegations of misconduct in Finland2012 Available from: http://www.tenk.fi/sites/tenk.fi/files/HTK_ohje_2012.pdfAccessed September 10, 2017
  • KurkoTLindenKPietiläKSandströmPAiraksinenMCommunity pharmacists’ involvement in smoking cessation: familiarity and implementation of national smoking cessation guideline in FinlandBMC Public Health20101044420670409
  • VermaAHarrisonATorunPVestboJEdwardsRThortonJAre pharmacists reducing COPD’s impact through smoking cessation and assessing inhaled steroid use?Respir Med201210623023421899999
  • TommeleinETollenaereKMehuysEBousseryKPharmaceutical care for patients with COPD in Belgium and views on protocol implementationsInt J Clin Pharm20143669770124858598
  • DriesenaarJADe SmetPAvan HultenRHuLvan DulmenSCommunication during counseling sessions about inhaled corticosteroids at the community pharmacyPatient Prefer Adherence2016102239225427843303
  • ChongWWAslaniPChenTFPharmacist-patient communication on use of antidepressants: a simulated patient study in community pharmacyRes Social Adm Pharm20141041943723787139
  • BellHTGranasAGEnmarkerLOmliRSteinsbekkANurses’ and pharmacists’ learning experiences from participating in interprofessional medication reviews for elderly in primary health care – a qualitative studyBMC Fam Pract2017183028241789
  • JyrkkäAKaitalaSAarnioHAiraksinenMToivoTKliininen haastattelu osana lääkehoitojen arviointeja ja omahoidon tukemista [Clinical interview as part of medication reviews and support for medication self-management]Dosis2017332233 Finnish
  • Finnish Medicines Agency, FimeaRational use of medicines through information and guidance, medicines information services: current state and strategy for 2020Fimea develops, assesses and informs serial publication 1/2012 Available from: http://www.fimea.fi/documents/160140/1153780/20853_Fimea_KAI_JULKAISUSARJA_Laakeinformaatiostrategia_1_2012_lopullinen_verkkoon.pdf/4c2e20b7-02a9-46e6-83ca-eebc55d2ad8cAccessed September 10, 2017
  • KansanahoHPuumalainenIVarunkiMAhonenRAiraksinenMImplementation of a professional program in Finnish community pharmacies in 2000–2002Patient Educ Couns20055727227915893208
  • LeikolaSTuomainenLPeuraSComprehensive medication review: development of a collaborative procedureInt J Clin Pharm20123451051422711383
  • PuumalainenIIPeuraSHKansanahoHMBenrimojCSIAiraksinenMSAProgress in patient counseling practices in Finnish community pharmaciesInt J Pharm Pract200513149156
  • SinnemäkiJSaastamoinenLKHannulaSPeuraSAiraksinenMStarting an automated dose dispensing service provided by community pharmacies in FinlandInt J Clin Pharm20143634535124310102
  • WesterlingAHynninenJHaikalaVAiraksinenMOpinion comparison concerning future information technology in Finnish community pharmaciesPharm World Sci20103278779420848207